Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,100.10
-15.50 (-1.39%)
At close: May 12, 2025, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 134.90 billion as of May 13, 2025. Its market cap has increased by 31.14% in one year.
Market Cap
134.90B
Enterprise Value
130.60B
Revenue
22.74B
Ranking
n/a
PE Ratio
30.61
Stock Price
1,100.10
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 134.90B, an increase of 47.10%. That is a compound annual growth rate of 10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 134.90B | 11.95% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,186.36B |
| Divi's Laboratories | 1,599.58B |
| Cipla | 1,195.31B |
| Mankind Pharma | 993.57B |
| Apollo Hospitals Enterprise | 966.52B |
| Zydus Lifesciences | 884.13B |
| Aurobindo Pharma | 676.29B |
| Alkem Laboratories | 591.43B |